We are live on
!
Find out more
Hudson Bay Capital Management Portfolio holdings
AUM
$29B
1-Year Est. Return
30.2%
This Fund
S&P 500
This Quarter
Est. Return
+23.54%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$5.72B
AUM Growth
+$1.72B
(+43%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-18.95%
Top 10 Holdings %
Top 10 Hldgs %
42.77%
Holding
683
New
195
Increased
120
Reduced
90
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Legend Biotech
LEGN
|
+$119M |
| 2 |
DraftKings
DKNG
|
+$63.9M |
| 3 |
NKLA
Nikola Corporation Common Stock
NKLA
|
+$49.9M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$45.5M |
| 5 |
CTEV
Claritev Corp
CTEV
|
+$42.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$187M |
| 2 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$43.2M |
| 3 |
Tesla
TSLA
|
+$38.7M |
| 4 |
Amazon
AMZN
|
+$37M |
| 5 |
CFFAU
CF Finance Acquisition Corp. Unit
CFFAU
|
+$27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.08% |
| 2 | Communication Services | 9.75% |
| 3 | Consumer Discretionary | 8.87% |
| 4 | Financials | 5.61% |
| 5 | Industrials | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Okta
OKTA
$26.2B
| $4.91M | 0.09% |
24,500
-31,100
| -56% | -$5.28M |
|
|
ZGYH
177
DELISTED
Yunhong International Class A Ordinary Shares
ZGYH
| $4.88M | 0.09% |
+500,000
| New | +$4.86M |
|
178
Artisan Partners
APAM
$3B
| $4.88M | 0.09% |
+150,000
| New | +$4.16M |
|
|
179
Tesla
TSLA
$1.31T
| $4.86M | 0.09% |
67,500
-715,500
| -91% | -$38.7M |
|
|
LIVK
180
DELISTED
LIV Capital Acquisition Corp. Class A Ordinary Shares
LIVK
| $4.84M | 0.08% |
492,000
+413,000
| +523% | +$4.02M |
|
181
GDS Holdings
GDS
$6.29B
| $4.77M | 0.08% |
+59,900
| New | +$3.71M |
|
|
SIOX
182
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $4.72M | 0.08% |
1,675,000
+325,000
| +24% | +$1.04M |
|
183
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $4.71M | 0.08% |
185,000
-45,000
| -20% | -$940K |
|
|
BTRS
184
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $4.69M | 0.08% |
460,541
+20,700
| +5% | +$205K |
|
185
Cigna
CI
$73.6B
| $4.69M | 0.08% |
25,000
-37,500
| -60% | -$7.11M |
|
|
BPMC
186
DELISTED
Blueprint Medicines
BPMC
| $4.68M | 0.08% |
60,000
-25,000
| -29% | -$1.69M |
|
|
SGMO
187
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $4.66M | 0.08% |
520,000
-155,000
| -23% | -$1.44M |
|
|
RMO
188
DELISTED
Romeo Power, Inc.
RMO
| $4.63M | 0.08% |
452,699
| – | – |
|
189
Lincoln National
LNC
$8.75B
| $4.6M | 0.08% |
+125,000
| New | +$4.4M |
|
|
SBBP
190
DELISTED
Strongbridge Biopharma plc.
SBBP
| $4.58M | 0.08% |
1,213,139
-196,280
| -14% | -$588K |
|
191
Cannae Holdings
CNNE
$644M
| $4.52M | 0.08% |
+110,000
| New | +$3.76M |
|
192
Uber
UBER
$159B
| $4.51M | 0.08% |
145,000
+35,000
| +32% | +$1.09M |
|
193
Gray Television
GTN
$513M
| $4.45M | 0.08% |
+318,935
| New | +$4.09M |
|
194
Frontdoor
FTDR
$5.78B
| $4.43M | 0.08% |
100,000
+60,000
| +150% | +$2.45M |
|
|
KYNB
195
Kyntra Bio
KYNB
$28.2M
| $4.43M | 0.08% |
4,372
+3,459
| +379% | +$3.21M |
|
196
Viatris
VTRS
$18.7B
| $4.42M | 0.08% |
275,000
+115,000
| +72% | +$1.86M |
|
197
Danaher
DHR
$147B
| $4.42M | 0.08% |
+28,200
| New | +$4.05M |
|
|
PMT
198
PennyMac Mortgage Investment
PMT
$818M
| $4.38M | 0.08% |
+250,000
| New | +$3M |
|
199
Warner Music
WMG
$13.8B
| $4.34M | 0.08% |
+147,200
| New | +$4.59M |
|
200
Skillsoft
SKIL
$83.5M
| $4.24M | 0.07% |
18,751
| – | – |
|
Similar funds
PCH
N
TWC
Hudson Bay Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Hudson Bay Capital Management held 683 positions worth $5.72B, up 43% from $3.99B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Hudson Bay Capital Management withdrew a net $1.08B in Q2 2020, closing 196 positions and reducing 90 holdings. Its most notable exit was Allergan plc, an estimated $187M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Hudson Bay Capital Management opened a new position in Legend Biotech worth $122M.
- Hudson Bay Capital Management's largest Q2 2020 buy was Legend Biotech: 3,056,342 shares worth $122M.
- Hudson Bay Capital Management added most to DraftKings in Q2 2020, an estimated $63.9M increase.
- Hudson Bay Capital Management's biggest Q2 2020 reduction was Tesla, cutting an estimated $38.7M.
- Hudson Bay Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $187M.
- Hudson Bay Capital Management's ten largest holdings make up 43% of its $5.72B portfolio in Q2 2020.
- Hudson Bay Capital Management opened 195 new positions and closed 196 in Q2 2020.
- Hudson Bay Capital Management's portfolio value rose 43% quarter-over-quarter to $5.72B.
Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.